Solar Industries India reported a strong second quarter with consolidated revenue of INR 3,519 crore, a 69% jump year-on-year. Profit after tax rose significantly to INR 650 crore, fueled by a robust defense order book currently standing at INR 17,568 crore. Management remains optimistic, indicating that the second half of the fiscal year is expected to outperform the first.
Solar Industries Q2 Profit Jumps 80% to 650 Crore
Consolidated Revenue: INR 3,519 crore (Up 69% YoY)
Consolidated PAT: INR 650 crore (Up from INR 361 crore YoY)
Reader Takeaway: Strong defense order inflow and robust revenue growth drive performance, though long procurement cycles remain a monitorable risk.
What just happened
Solar Industries India delivered a stellar performance for the quarter ended September. The company reported a 69% jump in consolidated revenue to INR 3,519 crore. Profit after tax grew by 80% to reach INR 650 crore, compared to INR 361 crore in the same quarter last year. EBITDA margins remained healthy at 29.02%.
Why this matters
The growth is underpinned by a massive total order book of INR 20,178 crore, with a significant portion (INR 17,568 crore) coming from the defense sector. The Pinaka rocket program alone accounts for a substantial pipeline of INR 9,000 crore, signaling high visibility for future earnings. The company has surpassed its expected growth pace, with management now confident of exceeding their full-year revenue guidance of INR 14,000 crore.
Defense and Business Update
Defense revenue for the first half of the year reached INR 1,935 crore, accounting for 27% of the company's total revenue. The company is accelerating indigenous product development, including UAVs and missile technology. Trials for their new 'Bhargavastra' product are expected to conclude by the end of this calendar year.
Risks to watch
Management identified potential headwinds including geopolitical instability, supply chain disruptions, and volatility in commodity prices. Additionally, investors should note that the defense procurement cycle is inherently long, which may cause timing gaps in the realization of new commercial orders.
What to track next
The company expects seasonal demand to make the second half of the fiscal year even stronger than the first. Investors should watch for updates on the completion of the Bhargavastra trials and the conversion of the Pinaka order pipeline into recognized revenue.